10-Q: Green Thumb Industries Q1 2026 Revenue Rises 7%

Green Thumb Industries reported a 7% increase in revenue for the first quarter of 2026, driven by new market entries and existing market growth, despite facing price compression.

Summary

• Green Thumb Industries reported total revenues of $300.19 million for the first quarter of 2026, a 7% increase compared to $279.54 million in the same period of 2025.
• The company's Retail segment generated $208.06 million in revenue, a 5% increase, while the Consumer Packaged Goods segment saw a slight decrease to $167.54 million from $170.28 million.
• Gross profit remained relatively flat at $143.65 million, with a gross margin of 48% in Q1 2026, down from 51% in Q1 2025, primarily due to licensing fees and price compression.
• Selling, general, and administrative expenses increased by 2% to $102.91 million.
• Net income attributable to Green Thumb Industries Inc. significantly increased by 85% to $15.40 million, or $0.07 per diluted share, compared to $8.31 million, or $0.04 per diluted share, in the prior year.
• The company ended the quarter with $344.51 million in cash and cash equivalents, an increase from $274.30 million at the end of 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, with strong revenue growth and a significant increase in net income driven by operational improvements and a one-time gain, despite margin pressures.

Positives

• Revenue increased by 7% to $300.19 million for the first quarter of 2026.
• Retail segment revenue grew by 5% to $208.06 million.
• Net income attributable to Green Thumb Industries Inc. rose by 85% to $15.40 million.
• Basic and diluted earnings per share increased to $0.07 from $0.04.
• Cash and cash equivalents increased to $344.51 million from $274.30 million.
• Successful launch of adult-use sales in Minnesota contributed to revenue growth.
• Growth in existing markets, particularly Florida, Ohio, and New York, supported revenue increases.
• The company resolved a commercial property lease dispute for $6.75 million.
• Received a $17 million arbitration award from Ascend Wellness Holdings Inc.

Negatives

• Gross margin decreased to 48% from 51% due to licensing fees and price compression.
• Consumer Packaged Goods segment revenue decreased by 2% to $167.54 million.
• Price compression and increased competition in select markets impacted revenue and margins.
• Licensing fees of $8.98 million were incurred in the current period.

Risks

• Cannabis remains illegal under U.S. federal law, with potential for changes in enforcement.
• State regulation of cannabis is uncertain and subject to change.
• The company may face limitations on ownership of cannabis licenses.
• Potential for U.S. Food and Drug Administration or U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives regulation.
• Restricted access to banking and other financial services due to cannabis business operations.
• Difficulties in acquiring additional financing.
• Intense competition from both legal and illicit markets.
• Dependence on the popularity and consumer acceptance of its brand portfolio.
• Limited trademark protection.
• Unfavorable tax treatment and potential significant tax liability due to Section 280E of the IRC.
• Risk of civil asset forfeiture and exposure to proceeds of crime statutes.
• Risks related to industry immaturity and limited established industry best practices.
• Risks related to agricultural operations and product liability claims.
• Potential for product recalls and unfavorable publicity or consumer perception.
• Adverse impact from rising or volatile energy costs and availability.
• Risks related to information technology systems, cyber-attacks, and security breaches.
• Reliance on third-party software providers.
• Loss of key personnel could negatively affect the business.
• Concentrated voting control and potential unpredictability due to capital structure.
• Sales of substantial amounts of Subordinate Voting Shares could adversely affect market price.

Future Outlook

The company expects to continue its growth strategy by expanding its Consumer Packaged Goods and Retail footprint within current markets through acquisitions and partnerships, and by scaling resources into new markets. New store opening plans will remain fluid depending on market conditions, licensing, construction, and capital allocation plans. The company expects to continue investing considerably in corporate infrastructure, particularly in stock-based compensation to attract and retain talent.

Management Comments

• The company's core business is manufacturing, distributing and marketing a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomons, Good Green, incredibles and RYTHM.
• The company owns and operates a national cannabis retail chain called RISE Dispensaries.
• Green Thumb expects to continue its growth strategy for the foreseeable future as the Company expands its Consumer Packaged Goods and Retail footprint within its current markets with acquisitions and partnerships, and scales resources into new markets.
• The Company takes a cautious approach in allocating its capital to maximize its returns while ensuring appropriate liquidity.
• Given the current uncertainty of the future economic environment, the Company has taken additional measures in monitoring and deploying its capital to minimize the negative impact on its current operations and expansion plans.

Industry Context

StockSavvy.ai notes that Green Thumb Industries' performance reflects the ongoing expansion and maturation of the U.S. cannabis market, with new state legalizations like Minnesota's adult-use sales contributing to top-line growth. However, the reported price compression and increased competition highlight the challenges faced by established multi-state operators (MSOs) in maintaining margins.

Comparison to Industry Standards

• Green Thumb's reported gross margin of 48% is within the typical range for vertically integrated cannabis operators, though it has seen a decline due to licensing fees and price pressures, which are common industry challenges.
• The company's revenue growth of 7% is a positive indicator in a competitive market, but it lags behind some of the more aggressive growth rates seen in rapidly expanding state markets.
• The significant increase in net income (85%) is a strong positive, suggesting improved operational efficiency or favorable one-time events, such as the arbitration award.
• The effective tax rate of 76.2% for Q1 2026 is exceptionally high, a direct consequence of Section 280E of the IRC, which is a standard challenge for all U.S. cannabis companies operating in a federally illegal environment.
• The company's focus on both retail (RISE) and consumer packaged goods aligns with the strategies of major MSOs like Curaleaf, Trulieve, and Verano Holdings, who also leverage multiple revenue streams.

Legal Proceedings

• A commercial property lease dispute filed in October 2019 was resolved on March 27, 2026, with the company remitting $6.75 million to the landlord.
• An arbitration award in favor of Green Thumb was received on February 5, 2026, related to a 2018 agreement with Ascend Wellness Holdings Inc., resulting in a $17 million settlement payment received on February 12, 2026.

Related Party Transactions

• The company holds a 33% ownership interest in RYTHM Inc. (RYM), accounted for using the equity method, with a carrying value of $159.49 million as of March 31, 2026.
• Green Thumb extended convertible notes receivable to RYM totaling $72 million as of March 31, 2026.
• Licensing fees of $8.98 million were incurred for brand intellectual property licensed from RYM.
• The company owed RYM $6.62 million as of March 31, 2026, related to license agreements.
• The License Agreements with RYM were amended on March 31, 2026, to replace revenue-based fees with fixed annual licensing fees of $70 million, effective April 1, 2026.
• Green Thumb provides operational support services to RYM, for which the company was owed $3.24 million as of March 31, 2026.

Stakeholder Impact

• Shareholders benefit from increased net income and earnings per share, alongside a growing cash position.
• Employees may see continued investment in corporate infrastructure and talent retention through stock-based compensation.
• Customers benefit from continued expansion of retail stores and product offerings.
• Suppliers may see increased demand due to revenue growth and market expansion.
• Creditors are assured by the company's compliance with credit facility covenants and strong working capital.

Next Steps

• Continue to expand Consumer Packaged Goods and Retail footprint within current markets through acquisitions and partnerships.
• Scale resources into new markets.
• Monitor market conditions, licensing, construction, and capital allocation plans for new store openings.
• Evaluate the impact of the U.S. Department of Justice's Final Order on rescheduling medical marijuana to Schedule III and await further guidance from the IRS.
• The DOJ will initiate an expedited administrative hearing process to consider broader rescheduling of marijuana, commencing June 29, 2026 and completing July 15, 2026.

Key Dates

Recommendation

The company demonstrates solid revenue growth and a significant increase in net income, bolstered by a one-time gain. However, margin pressures from licensing fees and price compression, coupled with the inherent risks of the cannabis industry and high effective tax rates due to Section 280E, warrant a cautious 'hold' stance. Investors should monitor the impact of the upcoming Schedule III rescheduling and the company's ability to manage competitive pressures.

Keywords

Green Thumb Industries, Cannabis, Retail, Consumer Packaged Goods, 10-Q, SEC Filing, Financial Results, Revenue, Gross Profit, Net Income, RISE Dispensaries, RYTHM Inc.